Skip to content

Structures and Small Molecule Inhibitors in Cellular and Animal Models

My WordPress Blog

Menu
  • Sample Page
Menu

We hypothesized which the vascular endothelium of the lung mediates APNs protective actions in this model because vascular permeability (wet:dry ratio and BAL protein concentration) is increased in APN/ mice

Posted on December 11, 2025 by president2010

We hypothesized which the vascular endothelium of the lung mediates APNs protective actions in this model because vascular permeability (wet:dry ratio and BAL protein concentration) is increased in APN/ mice. mice that have significantly reduced lung airspace APN but high serum APN levels experienced pulmonary inflammatory responses afteri.t.LPS that were much like those ofwtmice. These findings indicate the importance of serum APN in modulating LPS-induced ALI and suggest that conditions leading to hypoadiponectinemia (e.g. obesity) predispose to development of ALI through exaggerated inflammatory response in pulmonary vascular endothelium. Keywords:Adiponectin, acute lung injury, endothelium, T-cadherin == Introduction == Acute lung injury (ALI) is usually a life-threatening condition whose annual incidence in the United States has steadily increased over the last several decades. Recent data show that approximately 200,000 individuals are affected by this condition each year, and current estimates demonstrate a 3040% mortality with even greater numbers left with temporary or permanent disabilities (1). While the pathogenesis of ALI is usually complex, hallmark features include immune and endothelial cell activation, loss of vascular integrity, and accumulation of protein-rich fluid in the airspaces of the lung (23). Specific predisposing risk factors for the development of ALI in the face of systemic stress are incompletely defined. However, recent epidemiological data point to obesity as an important risk factor for development of ALI (47). In fact, clinical prediction scores utilizing obesity have stratified obese patients as being at higher risk for developing this condition (8). While certain adipocyte-derived hormones called adipokines contribute to a number of chronic inflammatory conditions including diabetes and cardiovascular disease, the impact of these hormones on the development of acute crucial illness such as ALI is not well comprehended (913). Adiponectin (APN), a highly abundant adipocyte-derived adipokine (with microgram/milliliter concentrations in serum) circulates as low, middle, and high molecular excess weight complexes. Paradoxically higher serum levels are present in lean, healthy individuals compared to obese and diabetic patients (14). Although APN was initially described as an insulin-sensitizing agent, more recent work has defined its pleiotropic anti-inflammatory and vascular protective role (1518). For example, clinical studies show an inverse relationship between APN levels and circulating concentrations of pro-inflammatory markers such as C-reactive protein, IL-6, and TNF- (1922). Moreover, experimental studies in mice demonstrate that APN contributes to immune homeostasis in the lung (23) and protects against inflammatory and post-ischemic injury in other tissue beds, including liver, muscle, brain, and heart (2427). The immune and vascular protective properties of APN led to speculation that hypoadiponectinemia may play a role in the development of ALI. To evaluate APNs role in ALI, we utilized a well-established model of LPS-induced lung injury in mice with targeted APN gene deletion. == Materials and methods == == Mice == All studies were performed using two-month aged, gender-matched mice. This time point was selected because it precedes the development of the vascular phenotype in APN/ mice (28). C57BL/6 APN/ mice were provided by N. Maeda, T. Funahashi, and Y. Matsuzawa (Osaka University or college, Osaka, Japan).WtC57BL/6 mice were obtained from Charles River laboratories. C57BL/6 T-cad/ mice were provided by B. Ranscht. All animal experiments were reviewed and approved by Boston Universitys Institutional Animal Care and Use Committee (IACUC). Mice were maintained in a 12-h light, 12-h dark routine and given food and waterad libitum. == Acute lung injury model == ALI was induced by the administration of a one-timei.t.injection of 100 g LPS (1 mg/ml). Delivery of LPS was performed using the tongue-pull maneuver in anesthetized mice. At Palomid 529 (P529) select time points after LPS administration lung tissue, serum, and BAL fluid were obtained for analysis. Lung wet:dry weights were performed as previously explained (28), and BAL protein concentration was Palomid 529 (P529) measured by Bradford Assay and Pierce bicinchoninic acid assay. == Mouse assessment score == Followingi.t.injection, mice were observed and scored by the mouse assessment score Palomid 529 (P529) (MAS) every four hours (with strict, IACUC-approved guidelines for euthanasia). Points were assigned based on four categories of physical appearance: a) Coat, 1 = easy, 2 = moderate ruffling, 3 = significant ruffling, b) Activity level, 1 = normal (exploring cage), 2 = lethargic (techniques slowly without activation), 3 = sedentary (moves RECA only with activation), 4 = immobile (minimal movement with activation), c) Respiratory effort, 1 = normal, 2 = labored, 3 = labored, irregular, d) Posture, 1 = moving or resting normally, 2 = huddled. Scores ranged from 4 (normal) to 12 (most abnormal). == Immunohistochemistry == Immuno-staining was performed on lung sections after antigen retrieval using Retrievagen A (Zymed, South San Francisco, CA) at 100C for 20 moments, and quenching endogenous peroxidases with 3% H2O2. Sections were blocked with 2% BSA in PBS followed by staining with main anti-CD45, anti-B220, anti-CD3, anti-F4/80 (BD Pharmingen, San Jose, CA),.

Recent Posts

  • Skin cells on a cover slip had been mounted within a chamber and whole cellular currents sized with low Clsolutions to reduce the contribution of flow-stimulated Clcurrents
  • (Portland, OR, USA) and the path and network were studied using Creation Pathway Examination (IPA, www
  • Raffaella Becagli to M
  • Quality control assays include digital microscopy and ThT staining
  • As a result of Protein A capture, the assay fits IgG1, IgG2 (Figure1B) and IgG4 (data not shown)

Recent Comments

  1. A WordPress Commenter on Hello world!

Archives

  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • December 2025
  • November 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021

Categories

  • Acetylcholine ??7 Nicotinic Receptors
  • Acetylcholine Nicotinic Receptors
  • Acyltransferases
  • Alpha1 Adrenergic Receptors
  • Angiotensin Receptors, Non-Selective
  • APJ Receptor
  • Calcium Channels
  • Carrier Protein
  • cMET
  • COX
  • DAT
  • Decarboxylases
  • Dipeptidyl Peptidase IV
  • DP Receptors
  • FFA1 Receptors
  • GlyR
  • H1 Receptors
  • HDACs
  • Hsp90
  • IGF Receptors
  • LXR-like Receptors
  • Miscellaneous Glutamate
  • Neurokinin Receptors
  • Nicotinic Acid Receptors
  • Nitric Oxide, Other
  • NO Synthase, Non-Selective
  • Non-selective Adenosine
  • Nucleoside Transporters
  • Opioid, ??-
  • Oxidative Phosphorylation
  • p70 S6K
  • PI 3-Kinase
  • Platelet-Activating Factor (PAF) Receptors
  • Potassium (KV) Channels
  • Potassium Channels, Non-selective
  • Prostanoid Receptors
  • Protein Ser/Thr Phosphatases
  • PTP
  • Retinoid X Receptors
  • Serotonin (5-ht1E) Receptors
  • Shp2
  • Sigma1 Receptors
  • Signal Transducers and Activators of Transcription
  • Sirtuin
  • Syk Kinase
  • T-Type Calcium Channels
  • Ubiquitin E3 Ligases
  • Ubiquitin/Proteasome System
  • Uncategorized
  • Urotensin-II Receptor
  • Vesicular Monoamine Transporters
© 2026 Structures and Small Molecule Inhibitors in Cellular and Animal Models | Powered by Minimalist Blog WordPress Theme